Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Berlex Launches Yasmin DTC Campaign; TV Spots Will Follow Print Ads

This article was originally published in The Pink Sheet Daily

Executive Summary

Yasmin print campaign revises previous ads called into question by FDA in a July 2003 "untitled" letter. Global sales of the oral contraceptive should approach $500 mil. in 2004.

You may also be interested in...



Barr To Resume Revised Seasonale DTC Ads By End Of January

Changes are being made to the voice-over in the television commercial for the extended-regimen oral contraceptive following a December FDA ad division letter. Barr will continue Seasonale DTC ads until the launch of Seasonique.

Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says

The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel